An analysis of tumor samples from patients with metastatic renal cell carcinoma also showed that patients who responded well to anti-PD-1 therapy had a higher relative abundance of Corynebacterium in contrast to non-responders [121,122]. Here, PDCD1 is linked to neoplasm.